Literature DB >> 9621664

[Anaphylactic shock associated with a central venous catheter impregnated with chlorhexidine and silver sulfadiazine].

E Terazawa1, K Nagase, T Masue, Y Niwa, I Fukao, H Shimonaka, T Yokoi, N Kondoh, S Dohi.   

Abstract

A 28 year-old male patient developed anaphylactic shock on separate occasions, possibly due to the contact with a central venous catheter impregnated with chlorhexidine and silver sulfadiazine. He was successfully resuscitated. On the second operation, blood basophils disappeared and plasma histamine level increased extremely up to 80 ng.ml-1 soon after anaphylactic shock. One year after the first shock, he did not develop anaphylactic shock following the insertion of a central venous catheter without the impregnation. Pin prick test and scratch test showed positive reactions only to chlorhexidine. Latex-specific anti-IgE antibody was not detected. Therefore, chlorhexidine was confirmed as the causative agent of anaphylactic shock. Because chlorhexidine is extensively used as an antiseptic drug in emergency rooms and intensive care units, we should be aware of the possibility of chlorhexidine induced anaphylactic reactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621664

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  3 in total

1.  Life-threatening anaphylactic shock due to chlorhexidine on the central venous catheter: a case series.

Authors:  Meilin Weng; Minmin Zhu; Wankun Chen; Changhong Miao
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Blood compatibility of widely used central venous catheters; an experimental study.

Authors:  Bengt Klarin; Javier Sanchez; Hulda Thorarinsdottir; Thomas Kander; Dorota Johansson; Bo Nilsson
Journal:  Sci Rep       Date:  2022-05-21       Impact factor: 4.996

3.  Fortified interpenetrating polymers - bacteria resistant coatings for medical devices.

Authors:  Seshasailam Venkateswaran; Orlando David Henrique Dos Santos; Emma Scholefield; Annamaria Lilienkampf; Peter J Gwynne; David G Swann; Kevin Dhaliwal; Maurice P Gallagher; Mark Bradley
Journal:  J Mater Chem B       Date:  2016-07-18       Impact factor: 6.331

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.